XML 83 R71.htm IDEA: XBRL DOCUMENT

Earnings per share (Tables)

12 Months Ended

Jun. 30, 2018

Text block1 [abstract]

Summary of earnings per share


		Consolidated
		2018 A$’000				2017 A$’000				2016 A$’000

Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(6,039	)			(10,670	)			(12,155	)
Non-controlling interest			—				—				93


Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(6,039	)			(10,670	)			(12,062	)


		Number				Number				Number

Weighted average number of ordinary shares used in calculating basic earnings per share			48,376,525				467,833,849				427,431,910


Weighted average number of ordinary shares used in calculating diluted earnings per share			48,376,525				467,833,849				427,431,910


		Cents				Cents				Cents
		A$				A$				A$

Basic earnings per share			(12.48	)			(2.28	)			(2.82	)
Diluted earnings per share			(12.48	)			(2.28	)			(2.82	)